Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

Raysearch Laboratories AB / Equity Bottom-Up

<ul><li>Q2 was weak, as already known from the July profit warning, mainly due to several larger US orders being delayed.</li><li>With the first delayed orders now materialising and RaySearch reiterating its +25% EBIT margin target for 2026, we expect a significantly stronger H2.</li></ul>

Q2 was weak, as already known from the July profit warning, mainly due to several larger US orders being delayed.With the first delayed orders now materialising and RaySearch reiterating its +25% EBIT margin target for 2026, we expect a significantly stronger H2.

RaySearch Laboratories (Q2 Review): H2 needs to deliver